Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years

Infection Control and Hospital Epidemiology - Tập 24 Số 9 - Trang 699-706 - 2003
Philip Carling1, Teresa T. Fung, Ann Killion, Norma Terrin, Michael Barza
1Infectious Diseases Section, Carney Hospital, 2100 Dorchester Avenue, Boston, MA 02124, USA.

Tóm tắt

AbstractObjective:To evaluate the impact of an interventional multidisciplinary antibiotic management program on expenditures for antibiotics and on the incidence of nosocomial infections caused by Clostridium difficile and antibiotic-resistant pathogens during 7 years.Design:Prospective study with comparison with preintervention trends.Setting:University-affiliated teaching hospital.Patients:All adult inpatients.Intervention:A multidisciplinary antibiotic management program to minimize the inappropriate use of third-generation cephalosporins was implemented in 1991. Its impact was evaluated prospectively. The incidence of nosocomial C. difficile and resistant Enterobacteriaceae infections as well as the rate of vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) were compared with those of National Nosocomial Infections Surveillance System hospitals of similar size.Results:Following implementation of the program, there was a 22% decrease in the use of parenteral broad-spectrum antibiotics (P < .0001) despite a 15% increase in acuity of patient care during the following 7 years. Concomitantly, there was a significant (P= .002) decrease in nosocomial infections caused by C. difficile and a significant (P = .02) decrease in nosocomial infections caused by resistant Enterobacteriaceae. The program also appeared to have a favorable impact on VRE rates without a sustained impact on MRSA rates.Conclusion:These results suggest that an ongoing multidisciplinary antibiotic management program may have a sustained beneficial impact on both expenditures for antibiotics and the incidence of nosocomial infection by C. difficile and resistant bacterial pathogens.

Từ khóa


Tài liệu tham khảo

10.1001/archinte.1997.00440360105012

10.1086/313559

10.1001/jama.1983.03340130046031

Frank, 1997, Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program, Clinical Performance and Quality Healthcare, 5, 180

10.1086/318126

10.1086/514742

10.1086/514753

10.1093/clinids/3.4.745

Johnson, 1996, Hospital Epidemiology and Infection Control, 399

10.1086/313431

10.7326/0003-4819-79-4-555

Carling, 2000, The favorable impact of the multi-disciplinary antibiotic management program analyzed over seven years

10.1093/clinids/23.1.118

10.1056/NEJM198306163082406

10.1086/513766

10.1086/346153

1995, Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC), MMWR, 44, 1

10.1016/S0732-8893(97)00115-6

Fishman, 2000, Principles and Practice of Infectious Diseases, 539

Murphy, 1996, Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapeutics

10.7326/0003-4819-128-12_Part_1-199806150-00005

10.1016/0002-9343(91)80083-X

Carling, 1993, The use of a standardized antibiotic monitoring program to document cost savings

10.1086/314874

Katz, 1988, Acquisition of Clostridium difficile from the hospital environment, Am J Epidemiol, 127, 128

1994, First Databank Blue Book of Pharmaceuticals

10.1001/jama.280.14.1270

10.1086/520193

10.1086/320185

10.1093/clinids/23.5.1020

Gerberding, 1999, Current Clinical Topics in Infectious Diseases

10.1093/infdis/157.5.869

10.1093/clinids/24.3.471

10.1016/0002-9343(90)90462-M

10.1093/infdis/151.3.388

10.1016/S0891-5520(05)70357-3

10.1001/jama.280.14.1233

10.1016/S0140-6736(86)92559-6

10.1001/archinte.1988.00380090091022

10.7326/0003-4819-120-4-199402150-00003

10.1086/520196

10.1086/514545

10.2307/30147068

10.1016/0196-6553(88)90053-3

10.2307/30145487

10.1056/NEJM200012283432604

10.1016/0002-9343(81)90553-2

10.7326/0003-4819-124-10-199605150-00004

10.1086/514743

10.1093/infdis/130.2.165

10.1086/502008

10.1056/NEJM199801223380406

Shanholtzer, 1992, Comparison of the VIDAS Clostridium difficile toxin A immuno assay with C-difficile culture and cytotoxin and latex tests, J Microbiol, 30, 1837